Hypotony as a presentation of giant cell arteritis [22]

Eye

Volumn 21, Issue 1, 2007, Pages 123-124

  Calcagni, A ^a   Claes, C A ^a   Maheshwari, M ^a   Jacks, A S ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; METHYLPREDNISOLONE; PREDNISOLONE;

ABDUCENS NERVE PARALYSIS; ADULT; AGING; ANOREXIA; CASE REPORT; CLINICAL FEATURE; COLOR VISION; DRUG MEGADOSE; ERYTHROCYTE SEDIMENTATION RATE; GIANT CELL ARTERITIS; HEADACHE; HUMAN; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE; JAW DISEASE; LETTER; MALE; MYALGIA; OPHTHALMOSCOPY; PTOSIS; RETINA FOVEA; RIGIDITY; SCOTOMA; THROMBOCYTE COUNT; VISUAL ACUITY; VISUAL FIELD; WEIGHT REDUCTION;

EID: 33846063848     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702436     Document Type: Letter

References (5)

1. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH et al. The American College of Rheumatology 1990: Criteria for the classification of giant cell arteritis. Arthritis Rheum 1990; 33(8): 1122-1128.
2. Hunder GG. Clinical features of GCA/PMR. Clin Exp Rheumatol 2000; 18(4 Suppl 20):S6-S8.
3. Hwang JM, Girkin CA, Perry JD, Lai JC, Miller NR, Hellmann DB. Bilateral ocular ischemic syndrome secondary to giant cell arteritis progressing despite corticosteroid treatment. Am J Ophthalmol 1999; 127(1): 102-104.
4. Killer HE, Holtz DJ, Kaiser HJ, Laeng RH. Diplopia, ptosis, and hepatitis as presenting signs and symptoms of giant cell arteritis. Br J Ophthalmol 2000; 84(11): 1319-1320.
5. Radda TM, Bardach H, Riss B. Acute ocular hypotony: A rare complication of temporal arteritis. Ophthalmologica (Basel) 1981; 182: 148-152.